I relish the opportunity to work with companies operating in a range of different sectors and investment banks on high profile and innovative capital markets transactions.
ckeastbutler@cooley.com
Claire Keast-Butler’s practice focuses on capital markets transactions. She represents issuers, investment banks and investors on initial public offerings and secondary offerings. She also regularly advises listed companies on corporate and securities law matters and corporate governance, and has considerable experience in public and private mergers and acquisitions and general corporate matters.
Download full bio
Exscientia Inks Investment of up to $525 Million
Immunocore $312.1 Million Aggregate Financing
RenalytixAI – $85 Million IPO
Capital Markets
Public Companies
Mergers & Acquisitions
Life Sciences
Aviation – Manned & Unmanned
Claire Keast-Butler is described as very approachable, easy to talk to and very good on the technical side of things.
University College LondonLLB, Bachelors of LawHonors, 1998
England & Wales
The Debate Over Dual-Class Shares in the UK June 15, 2021
Exscientia Inks Investment of up to $525 Million May 10, 2021
UK’s FCA Consults on Proposed Changes to the Listing Rules Relating to SPACs May 7, 2021
View all
Legal 500 – Equity Capital Markets
+44 20 7556 4211
Locations